Health Care/Hospital
Last patient in: Laminar Pharmaceuticals S.A. completes recruitment for CLINGLIO, the phase 2b/3 Clinical Trial of idroxioleic acid (LAM561) in combination with RT and TMZ for adults with newly diagnosed glioblastoma
140 patients have been recruited at sites in Spain, Italy, France and United Kingdom. The open readout of the trial is expected by late 2024. Laminar aims to submit regulatory filings or conditional marketing authorization by early 2025. PALMA DE MALLORCA, Spain, June 12, 2024 /PRNewswire/ -- Lam...
2024-06-12 02:15
1974
Ono Announces Results of Tender Offer to Acquire Deciphera Pharmaceuticals and Completion of Acquisition of Deciphera (a Wholly Owned Subsidiary of Ono)
OSAKA, Japan and WALTHAM, Mass., June 11, 2024 /PRNewswire/ -- Ono Pharmaceutical, Co., Ltd. (Chairman and CEO:Gyo Sagara, "Ono") today announced that it has successfully completed the tender offer, previously announced on April 30, 2024 to acquire all outstanding shares of common stock of a US b...
2024-06-11 20:30
1388
Blackmores' Launch of Nutriventia's TurmXTRA™ Based Range Validates Science of Concentrated Turmeric Ingredient
Blackmores' introduction of a range of products containing Nutriventia's TurmXTRA™ validates its science, safety, and efficacy MUMBAI, India, June 11, 2024 /PRNewswire/ -- Nutriventia Limited, a leading innovator of clinically proven, tech-driven clean ingredients for the health and wellness ind...
2024-06-11 20:00
1593
Supporting Inclusivity and Empowerment in Healthcare, Bayer Hosted Indonesia's "First Live Stream Using Indonesian Sign Language for Self-Care Health Education"
* Bayer Consumer Health Indonesia and Karya Insan Sejahtera Foundation (Precious One) conducted the "First Live Stream Using Indonesian Sign Language for Self-Care Health Education". * More than 100,000 people with Deaf disability in Indonesia received self-care health education through this ...
2024-06-11 18:17
1976
Meihua International Medical Technologies Co., Ltd. to Present at the Sidoti Small Cap Conference and Update Investors at the Emerging Growth Conference on June 13, 2024
YANGZHOU, China, June 11, 2024 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (Nasdaq: MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries inChina, is pleased to announce that it...
2024-06-11 18:00
2797
Biosion Today Presented Key Phase 2 POC Clinical Study Results for Bosakitug, an Anti-TSLP mAb, in Atopic Dermatitis Subjects at the Revolutionizing Atopic Dermatitis Conference
NEWARK, Del. and NANJING, China, June 11, 2024 /PRNewswire/ -- Biosion, a global, clinical-stage biotechnology company,today presented key results from the ADAMANT study, a phase 2 proof-of-concept trial in AD subjects treated with Bosakitug, a high potency anti-TSLP mAb, in a podium presentation...
2024-06-11 18:00
1320
111, Inc., Scrianen Announce Strategic Direct Supply Partnership to Expand Nationwide Reach and Improve Drug Accessibility
SHANGHAI, June 11, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream inChina, announced that the Company has ent...
2024-06-11 15:57
3263
HKBU-led research predicts humidity trends will result in widespread heat stress in China
HONG KONG, June 11, 2024 /PRNewswire/ -- A study conducted by a research team led by Hong KongBaptist University (HKBU) has discovered that there is a trend of increasing humidity in the northern part ofChina which is not observed in the south. This phenomenon will ultimately become a prominent f...
2024-06-11 14:59
1746
ITC final initial determination Ruled in favor of Hugel (no violation of Section 337)
SEOUL, South Korea, June 10, 2024 /PRNewswire/ -- Hugel Inc, a global total medical aesthetics company, announced that the Administrative Law Judge (ALJ) for its U.S. International Trade Commission(ITC) investigation issued an initial determination onJune 10th (local time) finding that "there is ...
2024-06-11 11:33
1663
Global Registrational Phase III Study of Olverembatinib for the Treatment of Patients with SDH-Deficient GIST Approved by the China CDE
SUZHOU, China, and ROCKVILLE, Md., June 11, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that the Center for Drug Evaluation (CDE) ofChina'...
2024-06-11 11:25
2941
Gannex Announces Poster Presentation of Positive Interim 12-Week Results from Phase II Clinical Trial of ASC41 in Patients with Biopsy-Confirmed MASH at EASL CONGRESS 2024
--Up to 68.2% mean relative reduction in liver fat content from baseline among biopsy-confirmed metabolic dysfunction-associated steatohepatitis (MASH) patients receiving 12-week treatment of ASC41 --Significant and clinically meaningful reductions in liver fat, alanine aminotransferase(ALT), as...
2024-06-11 08:10
1784
Full-Life Technologies Disclosed Preclinical Data of its NTSR1-targeting RDC Program FL-091 in an Oral Presentation at the 2024 SNMMI Annual Meeting
SHANGHAI and HEIDELBERG, Germany, June 10, 2024 /PRNewswire/ -- Full-Life Technologies (Full-Life), a fully integrated global radiotherapeutics company, released preclinical data of its NTSR1-targeting RDC program FL-091 in an oral presentation at the 2024 SNMMI (The Society of Nuclear Medicine a...
2024-06-11 08:00
1546
Element Six and Orbray partner to deliver the world's highest quality wafer-scale single crystal synthetic diamond
GRESHAM, Ore. and TOKYO, June 11, 2024 /PRNewswire/ -- Element Six
2024-06-11 08:00
3331
TraceLink Partners with Genpact to Expand Delivery of Digital Supply Chain Innovation for Healthcare and Life Sciences Sectors
TraceLink and Genpact solve supply chain complexities with advanced digital orchestration solutions. BOSTON, June 11, 2024 /PRNewswire/ -- TraceLink, a global leader in digital supply chain solutions, announced it has partnered with Genpact (NYSE: G), a global professional services and solutions...
2024-06-11 02:36
1703
Smartee Successfully Hosts GS Mandibular Repositioning Conference in Spain
MADRID, June 10, 2024 /PRNewswire/ -- The Smartee GS Mandibular Repositioning Technology Conference was successfully held inMadrid, Spain. This gathering provided a unique space for international dental professionals to engage in in-depth dialogue and exchange ideas on Smartee's innovative S8 ort...
2024-06-10 21:19
1303
Octapharma's continuing dedication to improving the lives of people with rare bleeding disorders to be showcased at ISTH 2024
* Octapharma to present new clinical and scientific findings for wilate® and Nuwiq® at the upcoming ISTH 2024 Congress * New data and clinical study developments to be showcased in seven oral presentations, two posters and two Supported Symposia LACHEN, Switzerland, June 10, 2024 /PRNewswire/...
2024-06-10 21:09
2159
Kangpu Biopharmaceuticals to Present Results from Phase 2a of KPG-818 in SLE at EULAR 2024
HEFEI, China, June 10, 2024 /PRNewswire/ -- Kangpu Biopharmaceuticals today announced that a poster tour presentation highlighting the Phase 2a clinical data of KPG-818 in patients with Systemic Lupus Erythematosus (SLE) will be presented at the upcoming Annual European Congress of Rheumatology E...
2024-06-10 20:00
1779
FDA Grants Fast Track Designation to GCBP and Novel Pharma's GC1130A
* FDA's Fast Track designation speeds up the development of new biologic drugs for rare diseases YONGIN, South Korea, June 10, 2024 /PRNewswire/ -- GC Biopharma (006280. KS) and Novel Pharma have announced that the U.S. FDA has granted Fast Track Designation for their jointly developed MPSIIIA ...
2024-06-10 16:18
2078
India Breakthrough: Bio Regenerative Precision Medicine Seminar Held in Hyderabad
HYDERABAD, India, June 10, 2024 /PRNewswire/ -- The Bio Regenerative Precision Medicine Seminar, held fromMay 18-20, 2024, at Le Méridien in Hyderabad, was a watershed moment inIndia's cell treatment journey. Prof. Dr Mike Chan, Chairman and Founder of European Wellness Biomedical Group (EWBG)...
2024-06-10 15:40
1904
J INTS BIO, ASCO 2024 - JIN-A02 showed tumor reductions including brain metastasis in the ongoing first-in-human, dose-finding Phase 1 clinical study
SEOUL, South Korea, June 10, 2024 /PRNewswire/ -- J INTS BIO provided an update of its ongoing Phase 1 clinical study of JIN-A02, a 4th generation EGFR-TKI for NSCLC treatment, during the 3rd of June poster session of the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting held at Mc...
2024-06-10 13:56
1657
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 314 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
7433
Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
2024-11-20 09:00
6834
